Intention Treatment for Anomia: Investigating Dose Frequency Effects and Predictors ofTreatment Response to Improve Efficacy and Clinical Translation
失智症的意向治疗:研究剂量频率效应和治疗反应的预测因素,以提高疗效和临床转化
基本信息
- 批准号:10597989
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdjuvantAgeAnomiaAphasiaBehaviorBehavior assessmentBrainBrain regionChronicChronic DiseaseClinicalCognitiveComputersDataDevelopmentDoseFamilyFrequenciesGesturesGoalsHandHealth Care CostsHealthcare SystemsHospitalizationImageImpairmentIndividualIntentionInterventionKnowledgeLanguageLearningLeftLesionLocationMaintenanceMemoryNeurologicNeurophysiology - biologic functionOutcomeParticipantPatientsPrediction of Response to TherapyQuality of lifeResearchResourcesRetrievalScheduleService delivery modelSocietiesStrokeTimeTrainingTreatment FactorTreatment outcomeVeteransWord ProcessingWorkaphasia rehabilitationclinical decision-makingclinical practiceclinical translationcognitive functioncostexperiencefollow-uphealth related quality of lifeimage processingimprovedlanguage impairmentmilitary veteranneuralneuroimagingnoveloptimal treatmentspredicting responseresponsestroke-induced aphasiatelehealththerapy designtreatment grouptreatment responsetrial comparingverbal
项目摘要
Difficulty retrieving words is one of the most common language complaints in individuals with stroke-
induced aphasia. The negative consequences related to word retrieval impairment include increased health
care costs and decreased quality of life. A variety of treatment approaches exist to improve word retrieval, and
most of the treatments result in immediate improvement on trained words. However, long-term improvement
and improvement on untrained words or behaviors is less common. Additionally, we currently know very little
about optimal treatment administration parameters and we know even less about predictors of treatment
response. Our current healthcare system is not resourced to provide ongoing treatment for individuals with
chronic aphasia. To make the best use of the clinical resources available for aphasia treatment, and to
maximize outcomes for Veterans with aphasia, we must: 1) develop clinically translatable treatments that yield
widespread and lasting effects and 2) develop clinically accessible ways of identifying who will acquire benefit
from a specific treatment approach. The proposed study in this Merit Review Application takes on these two
challenges by investigating dose frequency (massed vs. distributed practice) effects and identifying the
language, cognitive and neural predictors of response to Intention treatment (INT), a novel word retrieval
treatment. Our preliminary studies provide strong support for the proposed study, which we expect will
increase the efficacy, clinical translatability, and potential for use of INT as an adjuvant to other word retrieval
treatments. From a broader perspective, our results will help guide selection of the right treatment for the right
Veteran. This work has direct implications for clinical practice in aphasia rehabilitation and has the potential to
make a significant positive impact on the VA Healthcare System and on Veterans living with aphasia.
单词检索困难是中风患者最常见的语言主诉之一-
诱发失语症与单词提取障碍相关的负面后果包括健康状况的增加
护理费用和生活质量下降。存在各种各样的处理方法来提高单词检索,
大多数处理导致训练单词的立即改善。然而,长期改善
而对未经训练的词语或行为的改进则不太常见。此外,我们目前对
关于最佳的治疗管理参数,我们对治疗的预测因素知之甚少,
反应我们目前的医疗保健系统资源不足,无法为患有
慢性失语症充分利用失语症治疗的临床资源,
为了最大限度地提高退伍军人失语症的治疗效果,我们必须:1)开发临床上可翻译的治疗方法,
广泛和持久的影响和2)开发临床上可获得的方法来确定谁将获得受益
一种特殊的治疗方法。本Merit Review申请中的拟议研究采用了这两个
通过调查剂量频率(集中与分布式实践)效应和确定
语言、认知和神经预测对意图处理(INT)的反应,一种新的单词检索
治疗我们的初步研究为拟议研究提供了有力支持,我们预计这项研究将
提高INT作为其他词检索辅助工具的有效性、临床可译性和潜力
治疗。从更广泛的角度来看,我们的研究结果将有助于指导选择正确的治疗方法,
老兵这项工作对失语症康复的临床实践有直接的影响,并有可能
对VA医疗保健系统和患有失语症的退伍军人产生重大的积极影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Amy D Rodriguez其他文献
Effects of Gesture and Semantic-Phonologic Treatments for Verb Retrieval
手势和语义语音处理对动词检索的影响
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
Amy D Rodriguez;A. Raymer;L. Rothi - 通讯作者:
L. Rothi
Aphasia Rehabilitation Service Delivery in a Stroke Rehabilitation Unit in Australia: A Clinical Audit of Speech Pathology Practices
澳大利亚中风康复中心失语症康复服务的提供:言语病理学实践的临床审核
- DOI:
- 发表时间:
2016 - 期刊:
- 影响因子:0
- 作者:
L. Rej;S. Doeltgen;Amy D Rodriguez;Willem van Steenbrugge - 通讯作者:
Willem van Steenbrugge
People with aphasia share their views on self-management and the role of technology to support self-management of aphasia
失语症患者分享他们对自我管理的看法以及技术在支持失语症自我管理中的作用
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:2.2
- 作者:
L. Nichol;S. Wallace;Rachelle Pitt;Amy D Rodriguez;Zhi Zhi Diong;Annie J Hill - 通讯作者:
Annie J Hill
Apraxia of Speech: Change in Error Consistency Following a Multimodal intensive Treatment (MMiT)
言语失用症:多模式强化治疗 (MMiT) 后错误一致性的变化
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
Dana M Szeles;S. Harnish;Amy D Rodriguez;Fletcher Bowden;Stephanie Uhazie;J. Gilbert;Courtney Hamm;J. Rosenbek;Tiffany Fernandes;B. Crosson;L. Gonzalez;T. Conway - 通讯作者:
T. Conway
Crosswalk of participation self-report measures for aphasia to the ICF: what content is being measured?
向 ICF 提供失语症参与自我报告测量的 Crosswalk:正在测量哪些内容?
- DOI:
- 发表时间:
2015 - 期刊:
- 影响因子:2.2
- 作者:
C. Brandenburg;L. Worrall;Amy D Rodriguez;Karl S. Bagraith - 通讯作者:
Karl S. Bagraith
Amy D Rodriguez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Amy D Rodriguez', 18)}}的其他基金
One treatment, multiple targets: Prism adaptation and left brain stroke rehabilitation
一种治疗,多个目标:棱镜适应和左脑中风康复
- 批准号:
10016838 - 财政年份:2020
- 资助金额:
-- - 项目类别:
One treatment, multiple targets: Prism adaptation and left brain stroke rehabilitation
一种治疗,多个目标:棱镜适应和左脑中风康复
- 批准号:
10183359 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Intention Treatment for Anomia: Investigating Dose Frequency Effects and Predictors of Treatment Response to Improve Efficacy and Clinical Translation
失智症的意向治疗:研究剂量频率效应和治疗反应的预测因素,以提高疗效和临床转化
- 批准号:
10112761 - 财政年份:2020
- 资助金额:
-- - 项目类别:
One treatment, multiple targets: Prism adaptation and left brain stroke rehabilitation
一种治疗,多个目标:棱镜适应和左脑中风康复
- 批准号:
10411926 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Intention Treatment for Anomia: Investigating Dose Frequency Effects and Predictors ofTreatment Response to Improve Efficacy and Clinical Translation
失智症的意向治疗:研究剂量频率效应和治疗反应的预测因素,以提高疗效和临床转化
- 批准号:
10382269 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Acute Exercise Effects on Word Learning in Aging and Stroke-induced Aphasia
急性运动对衰老和中风引起的失语症的单词学习的影响
- 批准号:
9242454 - 财政年份:2016
- 资助金额:
-- - 项目类别:
相似海外基金
Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination
通过新型 ASP-1 佐剂组合恢复年龄依赖性疫苗无反应
- 批准号:
10458553 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination
通过新型 ASP-1 佐剂组合恢复年龄依赖性疫苗无反应
- 批准号:
10220588 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Restoring age-dependent vaccine unresponsiveness by a novel ASP-1 adjuvant combination
通过新型 ASP-1 佐剂组合恢复年龄依赖性疫苗无反应
- 批准号:
10620718 - 财政年份:2021
- 资助金额:
-- - 项目类别:
CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older
CoVPN 3005 - SARS-CoV-2 重组蛋白疫苗与佐剂对 18 岁及以上成人的功效、免疫原性和安全性
- 批准号:
10415762 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Dissecting the mechanism of age-specific adjuvant synergy in vitro and in vivo
剖析年龄特异性佐剂体外和体内协同作用的机制
- 批准号:
9108575 - 财政年份:2016
- 资助金额:
-- - 项目类别:
CoVPN 3005: Efficacy, Immunogenicity, and Safety of Two SARS-CoV-2 Recombinant Protein Vaccines with Adjuvant in Adults 18 Years of Age and Older - LC 3
CoVPN 3005:两种 SARS-CoV-2 重组蛋白疫苗与佐剂对 18 岁及以上成人的功效、免疫原性和安全性 - LC 3
- 批准号:
10570739 - 财政年份:2006
- 资助金额:
-- - 项目类别:
CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older
CoVPN 3005 - SARS-CoV-2 重组蛋白疫苗与佐剂对 18 岁及以上成人的功效、免疫原性和安全性
- 批准号:
10686595 - 财政年份:2006
- 资助金额:
-- - 项目类别:
CoVPN 3005 - Efficacy, Immunogenicity, and Safety of Two SARS-CoV-2 Recombinant Protein Vaccines with Adjuvant in Adults 18 Years of Age and Older
CoVPN 3005 - 两种 SARS-CoV-2 重组蛋白疫苗与佐剂对 18 岁及以上成年人的功效、免疫原性和安全性
- 批准号:
10581414 - 财政年份:2006
- 资助金额:
-- - 项目类别:
CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older
CoVPN 3005 - SARS-CoV-2 重组蛋白疫苗与佐剂对 18 岁及以上成人的功效、免疫原性和安全性
- 批准号:
10579557 - 财政年份:2006
- 资助金额:
-- - 项目类别: